Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy.
Saved in:
| Title: | Four-year follow-up from the ENCORE trial: A randomized, controlled, non-inferiority study comparing eliglustat to imiglucerase in patients with Gaucher disease type 1 stabilized on enzyme replacement therapy. |
|---|---|
| Authors: | Cox, Timothy M.1, Drelichman, Guillermo2, Balwani, Manisha3, Burrow, Thomas Andrew4, Lukina, Elena5, Rosenbloom, Barry6, Gaemers, Sebastiaan J.M.7, Angell, Jennifer7, Judith Peterschmitt, M.7 |
| Source: | Molecular Genetics & Metabolism. Feb2016, Vol. 117 Issue 2, pS37-S37. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
